July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Rahul Banerjee: DREAMM-7 with Belantamab Mafodotin in R/R Multiple Myeloma
Jul 16, 2025, 14:55

Rahul Banerjee: DREAMM-7 with Belantamab Mafodotin in R/R Multiple Myeloma

Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared a post on X about an article published in The Lancet Oncology by Vania Hungria et al:

“Just in time for ODAC, DREAMM-7 OS with belantamab in The Lancet Oncology by Vania Hungria et al.

Look at those survival curves! They estimate mOS of 7 years (!) with Bela-Vd based on modeling even in R/R myeloma. No T-cell collection, no CRS risk – great for patients around the word.

Question #1 for MM.

ODAC is whether we know optimal biological dosing schema for bela-maf to efficacy and toxicity. We don’t yet – but future trials and RW evidence will help us find out!

ASCO Daily News predictions by Doris Hansen and me.”

Rahul Banerjee

Title: Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial

Authors: Vania Hungria, Paweł Robak, Marek Hus, Vera Zherebtsova, Christopher Ward, P Joy Ho, Roman Hájek, Kihyun Kim, Sebastian Grosicki, Hanlon Sia, Adam Bryant, Marcelo Pitombeira de Lacerda, Gracia Aparecida Martinez, Anna Sureda Balarí, Irwindeep Sandhu, Claudio Cerchione, Peter Ganly, Meletios A Dimopoulos, Chengcheng Fu, Mamta Garg, Al-Ola Abdallah, Moshe E Gatt, Albert Oriol Rocafiguera, Michele Cavo, Robert Rifkin, Tomoaki Fujisaki, Michał Mielnik, Joseph Ficek, Alejandro Mantero, Nick Pirooz, Sybil Varghese, Joe Lee, Astrid McKeown, Rachel Rogers, Hena Baig, Lydia Eccersley, Sumita Roy-Ghanta, Pralay Mukhopadhyay, Jacqueline Nielsen, Joanna Opalinska, María-Victoria Mateos

Read Full Article.

Rahul Banerjee: DREAMM-7 with Belantamab Mafodotin in R/R Multiple Myeloma

More posts featuring Rahul Banerjee on OncoDaily.